A carregar...
A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer’s disease
OBJECTIVE: In patients with Alzheimer’s disease (AD) with psychosis or agitation that respond to haloperidol treatment, to evaluate the risk of relapse following discontinuation. METHODS: In outpatients with AD with symptoms of psychosis or agitation, responders to 20 weeks of haloperidol (0.5 to 5...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3685500/ https://ncbi.nlm.nih.gov/pubmed/21845596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/gps.2630 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|